Lukas Amon

Erlangen, BY 91052, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

NK cell-mediated tumor cell killing by bispecific innate cell engagers induces ADCC-mediated activation of primary human dendritic cells.

NK cell-mediated tumor cell killing by bispecific innate cell engagers induces ADCC-mediated activation of primary human dendritic cells.

Journal: Oncoimmunology
Published: January 18, 2026

Protocol for mapping murine myeloid bone marrow progenitors and their differentiation into CD103+ cDC1s and CD301b+ cDC2s.

Protocol for mapping murine myeloid bone marrow progenitors and their differentiation into CD103+ cDC1s and CD301b+ cDC2s.

Journal: STAR protocols
Published: January 12, 2026

Multi-Epitope DC Vaccines with Melanoma Antigens for Immunotherapy of Melanoma.

Multi-Epitope DC Vaccines with Melanoma Antigens for Immunotherapy of Melanoma.

Journal: Vaccines
Published: February 11, 2025

GM-CSF and specific type 2 cytokines induce CD103+ and CD301b+ cell states in cDC1s and cDC2s.

GM-CSF and specific type 2 cytokines induce CD103+ and CD301b+ cell states in cDC1s and cDC2s.

Journal: Cell reports
Published: February 10, 2025

Macrophages foster anti-tumor immunity by ZEB1-dependent cytotoxic T cell chemoattraction.

Macrophages foster anti-tumor immunity by ZEB1-dependent cytotoxic T cell chemoattraction.

Journal: Communications biology
Published: June 07, 2024

Protocol for mapping the heterogeneous dendritic cell network across the murine tissue landscape via high-dimensional flow cytometry.

Protocol for mapping the heterogeneous dendritic cell network across the murine tissue landscape via high-dimensional flow cytometry.

Journal: STAR protocols
Published: April 04, 2024

Unbiased high-dimensional flow cytometry identified NK and DC immune cell signature in Luminal A-type and triple negative breast cancer.

Unbiased high-dimensional flow cytometry identified NK and DC immune cell signature in Luminal A-type and triple negative breast cancer.

Journal: Oncoimmunology
Published: January 03, 2024

Clec12A, CD301b, and FcγRIIB/III define the heterogeneity of murine DC2s and DC3s.

Clec12A, CD301b, and FcγRIIB/III define the heterogeneity of murine DC2s and DC3s.

Journal: Cell reports
Published: November 07, 2023

XCR1 expression distinguishes human conventional dendritic cell type 1 with full effector functions from their immediate precursors.

XCR1 expression distinguishes human conventional dendritic cell type 1 with full effector functions from their immediate precursors.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 11, 2023

BCL2 Inhibition Reveals a Dendritic Cell-Specific Immune Checkpoint That Controls Tumor Immunosurveillance.

BCL2 Inhibition Reveals a Dendritic Cell-Specific Immune Checkpoint That Controls Tumor Immunosurveillance.

Journal: Cancer discovery
Published: November 28, 2022

Circumventing pyroptosis via hyperactivation shapes superior immune responses of human type 2 dendritic cells compared to type 3 dendritic cells.

Circumventing pyroptosis via hyperactivation shapes superior immune responses of human type 2 dendritic cells compared to type 3 dendritic cells.

Journal: European journal of immunology
Published: August 12, 2022

Immunoglobulin G-dependent inhibition of inflammatory bone remodeling requires pattern recognition receptor Dectin-1.

Immunoglobulin G-dependent inhibition of inflammatory bone remodeling requires pattern recognition receptor Dectin-1.

Journal: Immunity
Published: May 09, 2022
Showing 1-12 of 27

Last Updated: 09/26/2026